PuraMed BioScience Investigates the Integration of Hemp and THC-Free Cannabis Into Its Product Line PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, confirmed today that it is aggressively investigating the development of cannabinoid and hemp-based products to add to its line of medicinal formulations. PuraMed BioScience initially intends to manufacture THC-free formulations that create medicinal compounds that don’t produce the “high” associated with cannabis containing THC
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.